Publicaties

Kenniscentrum
Jaar
Auteur

Staging and profiling for schizophrenia spectrum disorders: Inter-rater reliability after a short training course

Berendsen, S., van der Paardt, J.W., Van, H., van Bruggen, M., Nusselder, H., Jalink, M., de Peuter, O.R., Peen, J., van Tricht, M.J. & De Haan, L.
Verschenen in Progress in Neuro-Psychopharmacology and Biological Psychiatry, Volume 99, 1-6 (2020)

Meta-analysis of cognitive functioning in patients with psychotic disorders and obsessive-compulsive symptoms

Dijkstra, L., Vermeulen, J.M., De Haan, L. & Schirmbeck, F.
Verschenen in European Archives of Psychiatry and Clinical Neuroscience volume, 271, 689–706 (2020)

Exploration of symptom dimensions and duration of untreated psychosis within a staging model of schizophrenia spectrum disorders

Berendsen, S., Van, H., van der Paardt, J.W., de Peuter, O.R., van Bruggen, M., Nusselder, H., Jalink, M., Peen, J., Dekker, J.J.M. & De Haan, L.
Verschenen in Early Intervention in Psychiatry, Volume 15, issue 3, 669-675 (2020)

The bumpy road to achieve reliability of clinical profile characteristics in psychosis and related disorders

Berendsen, S., van Tricht, M.J., Tedja, A., Burger, T., De Koning, M.B. & De Haan, L.
Verschenen in International Journal of Methods in Psychiatric Research, Volume 30, Issue 2, 1-8 (2020)

Burying Our Heads in the Sand: The Neglected Importance of Reporting Inter-Rater Reliability in Antipsychotic Medication Trials

Berendsen, S., Van, H., Verdegaal, L.M.A., van Tricht, M.J., Blankers, M. & De Haan, L.
Verschenen in Schizophrenia Bulletin, Vol. 46 no. 5, 1027-1029 (2020)

But I did not touch nobody!-Patients’ and nurses’ perspectives and recommendations after aggression on psychiatric wards-A qualitative study

Vermeulen, J.M., Doedens, P.R.M., Boyette, L.N.J., Spek, B., Latour, C.H.M.R.N. & De Haan, L.
Verschenen in Journal of Advanced Nursing , Volume75, Issue11, 2845-2854 (2019)

Childhood adversities and psychotic symptoms: The potential mediating or moderating role of neurocognition and social cognition

Mansueto, G., Schruers, K., Cosci, F., De Haan, L., Schirmbeck, F., GROUP Investigators & van Os, J.
Verschenen in Schizophrenia Research, Volume 206, 183-193 (2019)

Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use

Ferraro, L., La Cascia, C., Quattrone, D., Sideli, L., Matranga, D., Cappucio, V., WP2 EU-GEI Group, De Haan, L. & di Forti, M., et al.
Verschenen in Schizophrenia Bulletin, Volume 46, Issue 3, 517–529 (2019)

The Unhealthy Chicken or the Unhealthy Egg: Quitting Smoking Matters: Response to Hajek et al

Vermeulen, J.M., Schirmbeck, F. & Blankers, M.
Verschenen in American Journal of Psychiatry, 176, 575-576 (2019)

Psychometric properties of the DSM-5 Clinician-Rated Dimensions of Psychosis Symptom Severity

Berendsen, S., van der Veen, N.M., van Tricht, M.J. & De Haan, L.
Verschenen in Schizophrenia Research, 216, 416-421 (2019)

Use of Natural Language Processing to identify Obsessive Compulsive Symptoms in patients with schizophrenia, schizoaffective disorder or bipolar disorder

Chandran, D., Robbins, D.A., Chang, C.K., Shetty, H., Sanyal, J., Downs, J., Fok, M., Ball, M., Jackson, R., Stewart, R., Cohen, R., Vermeulen, J.M., Schirmbeck, F., De Haan, L. & Hayes, R.
Verschenen in Scientific Reports, 9, 14146, 1-7 (2019)

Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years

Vermeulen, J.M., van Rooijen, G., van de Kerkhof, M.P.J., Sutterland, A.L., Correll, C.U. & De Haan, L.
Verschenen in Schizophrenia Bulletin, Volume 45, Issue 2, 315-329 (2019)

Cognitive behavioral therapy for social activation in recent-onset psychosis: Randomized controlled trial

Pos, K., Franke, N., Smit, F., Wijnen, B.F.M., Staring, A.B.P., van der Gaag, M., Meijer, C., De Haan, L., Velthorst, E. & Schirmbeck, F.
Verschenen in Journal of Consulting and Clinical Psychology, 87 (2), 151–160 (2019)

Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis

Cakici, N., Bot, M., Lamers, F., Janssen, T., van der Spek, P.J., De Haan, L., Bahn, S., Penninx, B.W.J.H. & van Beveren, N.J.M.
Verschenen in European Neuropsychopharmacology, Volume 29, Issue 7, 835-846 (2019)

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

Alqarni, A., Todd, W.M., McGorry, P.D., Nelson, B., Markulevm C., Yuen, H.P., Schäfer, M.R., De Haan, L., Meyera, B.J. & et. al.
Verschenen in Schizophrenia Research, Volume 226, 44-51 (2019)

Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis

Malda, A., Boonstra, N., Barf, H., de Jong, S., Aleman, A., Addington, J., De Haan, L., Pijnenborg, G.H.M. & et al.
Verschenen in Frontiers in Psychiatry, 10, 345 (2019)

Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis

Wijnen, B.F.M., Thielen, F.W., Konings, S., Feenstra, T., van der Gaag, M., Veling, W., De Haan, L., Ising, H., Hiligsman, M., Evers, S.M.A.A., Smit, F. & Lokkerbol, J.
Verschenen in Expert Review of Pharmacoeconomics & Outcomes Research, Volume 20, 2020, Issue 3, 269-279 (2019)

Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study

Vermeulen, J.M., Wootton, R.E., Treur, J.L., Sallis, H.M., Jones, H.J., Zammit, S., van den Brink, W., Goodwin, G.M., De Haan, L. & Munafo, M.R.
Verschenen in The British Journal of Psychiatry, Volume 218 , Issue 2, 88 - 94 (2019)

Driving us mad: the association of Toxoplasma gondii with suicide attempts and traffic accidents – a systematic review and meta-analysis

Sutterland, A.L., Kuin, A., Kuiper, B., van Gool, T., Leboyer, M., Fond, G. & De Haan, L.
Verschenen in Psychological Medicine, Volume 49, Issue 10 , 1608-1623 (2019)

Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling

van Rooijen, G., van Rooijen, M., Maat, A., Vermeulen, J.M., Meijer, C.J., Ruhé, H.G., De Haan, L. & GROUP Investigators
Verschenen in Schizophrenia Researh, 208, 82-89 (2019)
ISO 9001 HKZNEN7510 Keurmerk

Disclaimer | Privacyverklaring | Cookiebeleid | © 2026 Arkin Onderzoek - Alle rechten voorbehouden | Realisatie: Lemon

Arkin